Contact this trialFirst, we need to learn more about you.
Serotonin Inverse Agonist/Antagonist
Pimavanserin for Neuropsychiatric Symptoms
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial will study the safety and tolerability of the drug pimavanserin when taken by adults and elderly patients with neuropsychiatric symptoms related to neurodegenerative diseases, over the course of 52 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service